High affinity binding of heparin by necrotic tumour cells neutralises anticoagulant activity: Implications for cancer related thromboembolism and heparin therapy

Thrombosis and Haemostasis

Volumn 86, Issue 2, 2001, Pages 616-622

  Morita, S ^a   Gebska, M A ^a   Kakkar, A K ^a   Scully, M F ^a  

^a THROMBOSIS RESEARCH INSTITUTE   (United Kingdom)

Author keywords

Cancer; Heparin binding; Thromboembolism

Indexed keywords

ANTITHROMBIN; BEMIPARIN; CERTOPARIN; DALTEPARIN; HEPARAN SULFATE; HEPARIN; HEPARIN BINDING PROTEIN; HISTONE; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; RIBOSOME PROTEIN; THROMBIN;

ANTICOAGULATION; ARTICLE; BINDING AFFINITY; CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER SURVIVAL; CELL DENSITY; CELL KILLING; CELL TYPE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG ACTIVITY; DRUG BINDING; FLUORESCENCE ACTIVATED CELL SORTER; HUMAN; HUMAN CELL; IDIOPATHIC DISEASE; MOLECULAR WEIGHT; NECROSIS; PANCREAS CARCINOMA; PRIORITY JOURNAL; PROTEIN LOCALIZATION; THROMBOEMBOLISM; TUMOR CELL LINE;

EID: 0034909586     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1616095     Document Type: Article

References (40)

1. Cell biology of tissue factor, the principal initiator of blood coagulation
2. Tumors: Wounds that do not heal. Similarities between tumor stroma generation and wound healing
3. Thrombin stimulates tumor-platelet adhesion in vitro and metastasis in vivo
4. Effect of thrombin treatment of tumor cells on adhesion of tumor cells to platelets in vitro and tumor metastasis in vivo
5. Protease-activated receptor 1 (PAR-1) is required and rate-limiting for thrombin-enhanced experimental pulmonary metastasis
6. Concentration-dependent dual effect of thrombin on impaired growth/apoptosis or mitogenesis in tumor cells
7. Soluble fibrin augments platelet/tumor cell adherence in vitro and in vivo, and enhances experimental metastasis
8. Heparin and cancer
9. Low-molecular-weight heparins and unfractionated heparin in the treatment of patients with acute venous thromboembolism: Results of a meta-analysis
10. Treatment of deep venous thrombosis with low-molecular-weight heparins. A meta-analysis
11. Actions of heparin that may affect the malignant process
12. Glycosaminoglycan-protein interactions: Definition of consensus sites in glycosaminoglycan binding proteins
13. Heparin binding to plasma proteins, an important mechanism for heparin resistance
14. Kinetics of intravenously administered heparin in normal humans
15. The disappearance of a low molecular weight heparin fraction (CY 216) differs from standard heparin in rabbits
16. The effect of trace amounts of tissue factor on thrombin generation in platelet rich plasma, its inhibition by heparin
17. A discontinous and highly porous sodium dodecyl sulfate-polyacrylamide slab gel system of high resolution
18. Identification and characterization of heparan sulfate-binding proteins from human lung carcinoma cells
19. Anticoagulant activities of heparin oligosaccharides and their neutralization by platelet factor 4
20. Neutralization of heparin-related saccharides by histidine-rich glycoprotein and platelet factor 4
21. Binding and internalization of heparin by vascular smooth muscle cells
22. Cell-surface heparan sulfate. Mechanisms of proteoglycan-cell association
23. Binding of heparin on the surface of cultured human endothelial cells
24. Heparin and heparan sulfate binding sites on B-16 melanoma cells
25. Heparin binds to human monocytes and modulates their procoagulant activities and secretory phenotypes. Effects of histidine-rich glycoprotein
26. Identification of cell-surface heparin/heparan sulfate-binding proteins of a human uterine epithelial cell line (RL95)
27. Murine HIP/L29 is a heparin-binding protein with a restricted pattern of expression in adult tissues
28. Nucleosomes bind to cell surface proteoglycans
29. Heparin binding and neutralising proteins
30. Trousseau's syndrome
31. Histopathological evaluation of apoptosis in cancer
32. Spontaneous apoptosis and proliferation in human pancreatic cancer
33. Apoptosis, oncosis, and necrosis. An overview of cell death
34. The shape of cell death
35. Cell death: The significance of apoptosis
36. The unique physiology of solid tumors: Opportunities (and problems) for cancer therapy
37. Apoptosis is associated with increased cell surface tissue factor procoagulant activity
38. Natural anticoagulant mechanisms
39. What do dysfunctional serpins tell us about molecular mobility and disease?
40. Mechanisms of hypercoagulation in malignancy and during chemotherapy